SANDHAM; David Andrew
Patent Applications and Registrations
Patent applications and USPTO patent grants for SANDHAM; David Andrew.The latest application filed is for "heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof".
Company Profile
6.21.35
- SANDHAM; David Andrew - Concord MA
- SANDHAM; David Andrew - Horsham GB
- Sandham; David Andrew - Cambridge MA
- Sandham; David Andrew - West Sussex GB
- Sandham, David Andrew - Sussex GB
Patent Activity
| Patent | Date |
|---|---|
| Heteroaryl Substituted Spiropiperidinyl Derivatives And Pharmaceutical Uses Thereof App 20220048909 - BUSHABOINA; Mallesh ; et al. | 2022-02-17 |
| Carboxamide Derivatives App 20210052554 - BALA; Kamlesh Jagdis ; et al. | 2021-02-25 |
| Combination Therapies App 20200277378 - Sabatos-Peyton; Catherine Anne ; et al. | 2020-09-03 |
| Carboxamide Derivatives App 20200268718 - BALA; Kamlesh Jagdis ; et al. | 2020-08-27 |
| Carboxamide Derivatives App 20190381011 - BALA; Kamlesh Jagdis ; et al. | 2019-12-19 |
| Carboxamide derivatives Grant 10,195,181 - Bala , et al. Fe | 2019-02-05 |
| Autotaxin inhibitors Grant 10,183,025 - Beattie , et al. Ja | 2019-01-22 |
| Autotaxin Inhibitors App 20180021345 - BEATTIE; David ; et al. | 2018-01-25 |
| Autotaxin inhibitors Grant 9,763,957 - Beattie , et al. September 19, 2 | 2017-09-19 |
| Carboxamide Derivatives App 20170014388 - BALA; Kamlesh Jagdis ; et al. | 2017-01-19 |
| Carboxamide derivatives Grant 9,403,810 - Bala , et al. August 2, 2 | 2016-08-02 |
| Autotaxin Inhibitors App 20160168119 - BAETTIG; Urs ; et al. | 2016-06-16 |
| Purine derivatives and their use in the treatment of disease Grant 9,334,271 - Briard , et al. May 10, 2 | 2016-05-10 |
| Carboxamide Derivatives App 20150329529 - BALA; Kamlesh Jagdis ; et al. | 2015-11-19 |
| Pyrrolopyridine derivatives and their use as CRTH2 antagonists Grant 9,169,251 - Bala , et al. October 27, 2 | 2015-10-27 |
| Novel Purine Derivatives And Their Use In The Treatment Of Disease App 20140336166 - Briard; Emmanuelle ; et al. | 2014-11-13 |
| Pyrrolopyridine Derivatives And Their Use As Crth2 Antagonists App 20140309254 - Bala; Kamlesh Jagdis ; et al. | 2014-10-16 |
| Pyrrolopyridine derivatives and their use as CRTH2 antagonists Grant 8,791,256 - Bala , et al. July 29, 2 | 2014-07-29 |
| Pyrrolopyridine Derivatives And Their Use As Crth2 Antagonists App 20130267518 - Bala; Kamlesh Jagdis ; et al. | 2013-10-10 |
| Organic compounds Grant 8,470,848 - Bala , et al. June 25, 2 | 2013-06-25 |
| Pyrrolopyridine derivatives and their use as CRTH2 antagonists Grant 8,455,645 - Bala , et al. June 4, 2 | 2013-06-04 |
| Pyrrolopyridine compounds and their use in treating disease Grant 8,431,703 - Sandham , et al. April 30, 2 | 2013-04-30 |
| Organic compounds Grant 7,888,383 - Sandham February 15, 2 | 2011-02-15 |
| Organic compounds App 20100210610 - Bala; Kamlesh Jagdis ; et al. | 2010-08-19 |
| Organic compounds App 20100204225 - Bala; Kamlesh Jagdis ; et al. | 2010-08-12 |
| Quinoline-2-one derivatives for the treatment of airways diseases Grant 7,745,462 - Fairhurst , et al. June 29, 2 | 2010-06-29 |
| Organic compounds for the treatment of inflammatory or allergic conditions Grant 7,678,826 - Axford , et al. March 16, 2 | 2010-03-16 |
| Pyrrolopyridine derivatives and their use as Crth2 antagonists Grant 7,666,878 - Bala , et al. February 23, 2 | 2010-02-23 |
| Organic Compounds App 20090221578 - Sandham; David Andrew | 2009-09-03 |
| Organic Compounds App 20090209552 - Sandham; David Andrew ; et al. | 2009-08-20 |
| Combinations Of Steroids And Methylxanthine Compounds App 20090018109 - Sandham; David Andrew | 2009-01-15 |
| Organic Compounds App 20080312229 - Sandham; David Andrew ; et al. | 2008-12-18 |
| Organic Compounds App 20080312230 - Sandham; David Andrew | 2008-12-18 |
| Organic Compounds App 20080312322 - Baettig; Urs ; et al. | 2008-12-18 |
| Organic Compounds App 20080287416 - Sandham; David Andrew ; et al. | 2008-11-20 |
| Crth2 Receptor Antagonists App 20080269335 - Sandham; David Andrew ; et al. | 2008-10-30 |
| Organic Compounds For the Treatment of Inflammatory or Allergic Conditions App 20080200466 - Axford; Jake ; et al. | 2008-08-21 |
| Pyrrolopyridine Derivatives And Their Use As Crth2 Antagonists App 20080114022 - Bala; Kamlesh Jagdis ; et al. | 2008-05-15 |
| Organic compounds App 20070185172 - Sandham; David Andrew ; et al. | 2007-08-09 |
| Quinoline-2-one derivatives for the treatment of airways diseases App 20070066607 - Fairhurst; Robin Alec ; et al. | 2007-03-22 |
| 8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors App 20060173181 - Bhalay; Gurdip ; et al. | 2006-08-03 |
| 8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors App 20060106214 - Bhalay; Gurdip ; et al. | 2006-05-18 |
| 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors Grant 7,019,136 - Bhalay , et al. March 28, 2 | 2006-03-28 |
| Organic compounds Grant 6,921,757 - Cuenoud , et al. July 26, 2 | 2005-07-26 |
| 8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors Grant 6,919,337 - Bhalay , et al. July 19, 2 | 2005-07-19 |
| 8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors App 20050054660 - Bhalay, Gurdip ; et al. | 2005-03-10 |
| 8-Quinolinxanthine and 8-isoquinolinxant hine derivatives as PDE 5 inhibitors App 20040038996 - Bhalay, Gurdip ; et al. | 2004-02-26 |
| 8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors App 20030171384 - Bhalay, Gurdip ; et al. | 2003-09-11 |
| Organic compounds App 20030158163 - Cuenoud, Bernard ; et al. | 2003-08-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 